Internal Medicine, Pulmonary Disease · Dallas, TX
NPI
1245467737
Since 2009
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
3410 Worth St Ste 250
Dallas, TX, 75246
Phone (214) 820-6856
Groups this clinician bills Medicare through
Medicare paid, 2024
$38K
1,223 services
Medicare patients, 2024
219
Average age 73
Drug cost, 2024
$3.8M
1,522 prescriptions
Company payments, 2025
$6,976
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Susan K Mathai was code 94010 (pulmonary function testing), 278 times for 150 patients. In total Susan K Mathai billed 1,223 services in 16 codes, and Medicare paid $38K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-04-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 94010 Pulmonary Function Testing | Facility | 278 | 150 | $5.82 | $1,619 |
| 94729 Pulmonary Function Testing | Facility | 275 | 156 | $6.38 | $1,756 |
| 94618 Pulmonary Function Testing | Facility | 246 | 144 | $16.54 | $4,069 |
| 99214 Office E&M - Established | Facility | 205 | 130 | $72.00 | $15K |
| 99215 Office E&M - Established | Facility | 89 | 69 | $102.29 | $9,104 |
| 94621 Pulmonary Function Testing | Facility | 41 | 41 | $47.77 | $1,958 |
| 94726 Pulmonary Function Testing | Facility | 27 | 27 | $8.83 | $238 |
| 94060 Pulmonary Function Testing | Facility | 22 | 22 | $7.86 | $173 |
| 99205 Office E&M - New | Facility | 20 | 20 | $136.72 | $2,734 |
By year: 2022 $40K for 1,171 services; 2023 $34K for 1,108 services; 2024 $38K for 1,223 services.
Medicare prescription drug claims, 2024
In 2024, the drug Susan K Mathai prescribed most often to Medicare patients was Ofev (Nintedanib Esylate), with 235 prescriptions and refills. In total Susan K Mathai wrote 1,522 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ofev Nintedanib Esylate | 235 | 243 | 33 | $3.0M |
| Prednisone Generic | 189 | 422 | 69 | $2,358 |
| Mycophenolate Mofetil Generic | 184 | 386 | 53 | $20K |
| Pirfenidone Generic | 119 | 119 | 17 | $153K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 91 | 211 | 33 | $884 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 89 | 93 | 33 | $2,246 |
| Furosemide Generic | 65 | 157 | 21 | $420 |
| Omeprazole Generic | 63 | 170 | 26 | $1,081 |
| Potassium Chloride Generic | 29 | 48 | Under 11 | $322 |
| Methotrexate Methotrexate Sodium | 29 | 83 | Under 11 | $639 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 24 | 48 | Under 11 | $29K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 22 | 44 | Under 11 | $4,290 |
| Bumetanide Generic | 21 | 21 | Under 11 | $328 |
| Azelastine Hcl Generic | 21 | 41 | Under 11 | $543 |
| Spiriva Handihaler Tiotropium Bromide | 21 | 27 | Under 11 | $15K |
Brand drugs: 475 claims; generic drugs: 1,047 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Susan K Mathai $6,976 ($6,976 in general payments such as food, travel and fees) from 4 companies. The largest payer was GlaxoSmithKline, LLC. with $5,246.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.